Isabel Kalofonos

Insider Reports History

Entity
Individual
Location
C/O Immunogen, Inc., 830 Winter Street, Waltham, MA
Signature
Marc Wilson, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Isabel Kalofonos:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ImmunoGen, Inc. SVP & CHIEF COMMERCIAL OFFICER Restricted Stock Unit 0 $0 $29.30 Feb 12, 2024 Direct
ImmunoGen, Inc. SVP & CHIEF COMMERCIAL OFFICER Stock Option (Right to Buy) 0 $0 $4.56 Feb 12, 2024 Direct

Insider Reports Filed by Isabel Kalofonos

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRNX Crinetics Pharmaceuticals, Inc. Dec 16, 2024 0 $0 3 Dec 30, 2024 Chief Commercial Officer
IMGN ImmunoGen, Inc. Feb 12, 2024 3 $0 4 Feb 12, 2024 SVP & CHIEF COMMERCIAL OFFICER
IMGN ImmunoGen, Inc. Feb 1, 2024 1 $0 4 Feb 5, 2024 SVP & CHIEF COMMERCIAL OFFICER
IMGN ImmunoGen, Inc. Apr 28, 2023 2 $0 4 May 2, 2023 SVP & CHIEF COMMERCIAL OFFICER
IMGN ImmunoGen, Inc. Apr 24, 2023 0 $0 3 May 2, 2023 SVP & CHIEF COMMERCIAL OFFICER